[Genetic predisposition to childhood cancer]

Area of Science:

• Oncology
• Human Genetics
• Pathology

Background:

• Childhood cancer often involves genetic predisposition, necessitating collaboration among specialists.
• Understanding genetic factors is crucial for accurate diagnosis, effective treatment, and prevention of secondary cancers.
• Syndromes like Li-Fraumeni and CMMRD highlight the link between germline variants and cancer risk.

Purpose of the Study:

• To discuss criteria for identifying genetic tumor predisposition syndromes in children.
• To explore the relationship between somatic and germline genetic variants in cancer development.
• To outline the clinical implications of diagnosing genetic tumor predisposition syndromes.

Main Methods:

• Review of clinical examples including Li-Fraumeni syndrome, CMMRD, medulloblastoma, neuroblastoma, and hematological neoplasias.
• Analysis of criteria for genetic tumor predisposition syndromes.
• Discussion of somatic vs. germline variant interactions and clinical consequences.

Main Results:

• Genetic tumor predisposition syndromes have direct impacts on cancer treatment strategies, such as avoiding radiotherapy in Li-Fraumeni syndrome to prevent secondary tumors.
• Predictive genetic diagnostics can identify at-risk family members.
• Integration of at-risk individuals into cancer surveillance programs improves overall survival.

Conclusions:

• Multidisciplinary collaboration is essential for managing genetic predisposition to childhood cancer.
• Genetic diagnostics and tailored surveillance are vital for improving outcomes in hereditary cancer syndromes.
• Early identification and management of genetic tumor predisposition syndromes significantly enhance patient survival rates.